Rufinamide Oral Suspension is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients aged 1 year old and older, and in adults.
Toprail Pharmaceuticals won for its Gluco-To-Go oral glucose gels, and Intuity Medical was a finalist for its POGO Automatic Blood Glucose Monitoring System.
Sponsored by Deloitte Private and The Wall Street Journal, the program recognizes outstanding U.S. private companies and the achievements of their management teams.